BHI Arthritis Tablet

Manufacturer
MediNatura Inc
Effective date
2024-12-17
Label type
HUMAN OTC DRUG LABEL
Version
6
Source
full-release
Hydrated at
2026-06-01 02:29:41

Label at a glance#

ProductBHI Arthritis
Active ingredientARNICA MONTANA ROOT, BERBERIS VULGARIS ROOT BARK, BRYONIA ALBA WHOLE, CAUSTICUM, CITRULLUS COLOCYNTHIS FRUIT PULP, SOLANUM DULCAMARA TOP, FERROSOFERRIC PHOSPHATE, LEDUM PALUSTRE TWIG, LYCOPODIUM CLAVATUM SPORE, RANUNCULUS BULBOSUS, RHODODENDRON AUREUM LEAF, TOXICODENDRON PUBESCENS LEAF, SULFUR
Label structure8 sections

Indications and uses

For the temporary relief of minor arthritis pain, joint stiffness.

Dosage and administration

At first sign of symptoms: Adults: 1 tablet every 1/2 to 1 hour until symptoms lessen, then continue with standard dosage. Standard dosage: Adults:  Take 1-2 tablets every 4 to 6 hours. Do not exceed 12 tablets in 24 hours. For children under 18 , consult your health professional. Allow tablets to dissolve completely in the mouth, do not swallow.

Label contents#

Full prescribing information#

ACTIVE INGREDIENTS

OTC - ACTIVE INGREDIENT SECTION

Each tablet contains: *Arnica montana, radix 6X, *Berberis vulgaris 8X, *Bryonia alba 4X, 8X, 12X, 30X, Causticum 8X, *Colocynthis 5X, *Dulcamara 6X, Ferrum phosphoricum 12X, *Ledum palustre 6X, *Lycopodium clavatum 10X, *Ranunculus bulbosus 6X, *Rhododendron chrysanthum 8X, *Rhus toxicodendron 4X, 8X, 12X, 30X, *Sulphur 10X 15.8 mg each.

*Natural Ingredients

INACTIVE INGREDIENTS

INACTIVE INGREDIENT SECTION

Inactive Ingredients: **Dextrose, ** Lactose, Magnesium Stearate, **Maltodextrin
**contains one or more of these ingredients.

PURPOSE

OTC - PURPOSE SECTION

Arthritis Pain Relief Tablets

Relieves:

• Arthritis Pain

• Joint Stiffness

WARNINGS

WARNINGS SECTION

If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. If symptoms persist or worsen, a health professional should be consulted.Do not use if known sensitivity to Arthritis or any of its ingredients exists.

USES

INDICATIONS & USAGE SECTION

For the temporary relief of minor arthritis pain, joint stiffness.

Directions

DOSAGE & ADMINISTRATION SECTION

At first sign of symptoms: Adults: 1 tablet every 1/2 to 1 hour until symptoms lessen, then continue with standard dosage.

Standard dosage: Adults: Take 1-2 tablets every 4 to 6 hours. Do not exceed 12 tablets in 24 hours.

For children under 18, consult your health professional.

Allow tablets to dissolve completely in the mouth, do not swallow.

KEEP OUT OF REACH OF CHILDREN

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

BHI Arthritis Tablet.jpgBHI Arthritis Tablet.jpg

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
ed912195-5da0-0f2f-6f4b-3ef17710cbe3Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
62795-1010-2BHI Arthritis100 in 1 BOTTLETABLET1006
62795-1010-3BHI Arthritis100 in 1 BOTTLETABLET1006
62795-1010-3BHI Arthritis1 in 1 CARTONTABLET16

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
62795-1010BHI ARTHRITIS (ARNICA MONTANA ROOT, BERBERIS VULGARIS ROOT BARK, BRYONIA ALBA WHOLE, CAUSTICUM, CITRULLUS COLOCYNTHIS FRUIT PULP, SOLANUM DULCAMARA TOP, FERROSOFERRIC PHOSPHATE, LEDUM PALUSTRE TWIG, LYCOPODIUM CLAVATUM SPORE, RANUNCULUS BULBOSUS, RHODODENDRON AUREUM LEAF, TOXICODENDRON PUBESCENS LEAF , AND SULFUR) TABLET [MEDINATURA INC]6Current NDC, Legacy NDC, 3 package rows20241219_d58c4651-2871-4beb-b1f5-e01a793cbc44.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
62795-1010-2EA - Each62795-1010536c6acb-ed3e-4211-89c4-902de982d59312015-10-02
62795-1010-3EA - Each62795-1010fca885c4-a910-4eba-9a1e-0822ee4b340012023-06-06

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
ARNICA MONTANA ROOTACTIVE INGREDIENTMUE8Y113271
BERBERIS VULGARIS ROOT BARKACTIVE INGREDIENT1TH8Q20J0U1
BRYONIA ALBA WHOLEACTIVE INGREDIENT56K0VVT47P1
CAUSTICUMACTIVE INGREDIENTDD5FO1WKFU1
CITRULLUS COLOCYNTHIS FRUIT PULPACTIVE INGREDIENT23H32AOH171
FERROSOFERRIC PHOSPHATEACTIVE INGREDIENT91GQH8I5F71
LEDUM PALUSTRE TWIGACTIVE INGREDIENT877L01IZ0P1
LYCOPODIUM CLAVATUM SPOREACTIVE INGREDIENTC88X29Y4791
RANUNCULUS BULBOSUSACTIVE INGREDIENTAEQ8NXJ0MB1
RHODODENDRON AUREUM LEAFACTIVE INGREDIENTIV92NQJ73U1
SOLANUM DULCAMARA TOPACTIVE INGREDIENTKPS1B1162N1
SULFURACTIVE INGREDIENT70FD1KFU701
TOXICODENDRON PUBESCENS LEAFACTIVE INGREDIENT6IO182RP7A1
ARNICA MONTANA ROOTACTIVE MOIETYMUE8Y113271
BERBERIS VULGARIS ROOT BARKACTIVE MOIETY1TH8Q20J0U1
BRYONIA ALBA WHOLEACTIVE MOIETY56K0VVT47P1
CAUSTICUMACTIVE MOIETYDD5FO1WKFU1
CITRULLUS COLOCYNTHIS FRUIT PULPACTIVE MOIETY23H32AOH171
FERROSOFERRIC PHOSPHATEACTIVE MOIETY91GQH8I5F71
LEDUM PALUSTRE TWIGACTIVE MOIETY877L01IZ0P1
LYCOPODIUM CLAVATUM SPOREACTIVE MOIETYC88X29Y4791
RANUNCULUS BULBOSUSACTIVE MOIETYAEQ8NXJ0MB1
RHODODENDRON AUREUM LEAFACTIVE MOIETYIV92NQJ73U1
SOLANUM DULCAMARA TOPACTIVE MOIETYKPS1B1162N1
SULFURACTIVE MOIETY70FD1KFU701
TOXICODENDRON PUBESCENS LEAFACTIVE MOIETY6IO182RP7A1
LACTOSEINACTIVE INGREDIENTJ2B2A4N98G1
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I301

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 19 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
62795-101062795-1010-3, 62795-1010-2

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 17 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 6 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30TABLET / ORAL980 mgExact identifier — unii+route+dosage form
3 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30TABLET / ORAL980 mgExact identifier — unii+route+dosage form
3 equally ranked IID candidates
LACTOSELACTOSEJ2B2A4N98GTABLET / ORAL2500 mgExact identifier — unii+route+dosage form
3 equally ranked IID candidates
LACTOSELACTOSEJ2B2A4N98GTABLET / ORAL2500 mgExact identifier — unii+route+dosage form
3 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30TABLET / ORAL980 mgExact identifier — unii+route+dosage form
3 equally ranked IID candidates
LACTOSELACTOSEJ2B2A4N98GTABLET / ORAL2500 mgExact identifier — unii+route+dosage form
3 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
BHI ArthritisARNICA MONTANA ROOT, BERBERIS VULGARIS ROOT BARK, BRYONIA ALBA WHOLE, CAUSTICUM, CITRULLUS COLOCYNTHIS FRUIT PULP, SOLANUM DULCAMARA TOP, FERROSOFERRIC PHOSPHATE, LEDUM PALUSTRE TWIG, LYCOPODIUM CLAVATUM SPORE, RANUNCULUS BULBOSUS, RHODODENDRON AUREUM LEAF, TOXICODENDRON PUBESCENS LEAF , AND SULFURMediNatura Incd58c4651-2871-4beb-b1f5-e01a793cbc442024-12-17WarningsExact identifier
ndc (package): 62795-1010-3
ndc (package): 62795-1010-2
ndc (product): 62795-1010
ndc11 (package): 62795101003
ndc11 (package): 62795101002
spl id: 2e0067b6-5a38-4cbe-845f-c02c9b8f485b
spl set id: d58c4651-2871-4beb-b1f5-e01a793cbc44

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.